Atabay Kimya Sanayi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global Paediatric Influenza Treatment IndustryThe Global Paediatric Influenza Treatment Industry is set to undergo a transformative journey, with projections soaring from US$ 578.2 million in 2022 to an impressive US$ 847.7 million by 2032. This substantial growth, attributed to a robust Compound Annual Growth Rate.

New yorkUnited statesAsia pacificOseltamivir zanamivirAtabay kimya sanayiGlaxosmithkline plcCompetition companiesRoche ltdTeva pharmaceuticalMarket insights incConsumer technologyGreater new york chamberGlobal paediatric influenza treatment industryCompound annual growth ratePaediatric influenza treatment industryCustomized report